Telmisartan, a selective angiotensin II type 1 receptor blocker, has recently been shown to act as a partial agonist for peroxisome proliferator-activated receptor gamma (PPARγ). To understand how ...
Munich, Germany - Final results of a head-to-head comparison of the ACE inhibitor enalapril and the angiotensin receptor blocker (ARB) telmisartan show the agents are comparably renoprotective in ...
Telmisartan, a drug widely used to help control blood pressure, may have uniquely potent activity in preventing stroke, according to a new study conducted in an animal model. Telmisartan, a drug ...
May 22, 2007 (Chicago, IL) – One year of treatment with the novel angiotensin receptor blocker (ARB) telmisartan provided greater reductions in proteinuria when compared with losartan, a drug approved ...
Scientists in Barcelona discover that two approved drugs — pemafibrate and telmisartan — may reduce liver fat and prevent metabolic liver damage. (Image: Pexels) Two medicines available in your local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback